公司资料

Palvella Therapeutics 股价、新闻与催化剂

股票代码:: PVLA
交易所:: NASDAQ
行业:: Biopharma
所在地:: Germany

股价为何变动

目前无法获取 PVLA 的收盘价变动背景。

公司概览

业务概览

Pieris was a biotechnology company focused on engineered proteins and respiratory disease before its strategic decline and restructuring. Its platform centered on antibody-mimetic science and immunology.

所在地与行业分类

Headquartered in Germany and listed on NASDAQ as an ADR before restructuring, Pieris sat in specialty biotechnology.

商业模式特征

The business depended on platform validation, clinical data, and partnership progress to create value.

生物医药行业定位

Pieris belongs to the historical biotech-restructuring category rather than the current live public-company set.

未来催化剂

Pieris is now mostly a legacy / closeout story, so the catalysts are any strategic or asset-resolution update rather than a fresh pipeline event. The market is watching what remains after the unwind.

近期新闻

新闻标题由机器翻译，详情为英文原文。

相似股票

商业成熟度、治疗领域或催化剂模式相近的同行公司。